Lataa...
Adjunctive perampanel for refractory partial-onset seizures: Randomized phase III study 304
OBJECTIVE: To assess efficacy and safety of once-daily 8 or 12 mg perampanel, a noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptor antagonist, when added to concomitant antiepileptic drugs (AEDs) in the treatment of drug-resistant partial-onset seizures. METHODS: Th...
Tallennettuna:
| Päätekijät: | , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Lippincott Williams & Wilkins
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3413761/ https://ncbi.nlm.nih.gov/pubmed/22843280 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3182635735 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|